Theranostics for Cancer Targeting

1 Edición - 1 de abril de 2027
Última edición
Editores: Ranjita Shegokar, Yashwant Pathak
Idioma: Inglés

This groundbreaking Theranostic book delivers the definitive roadmap for the next generation of precision oncology by systematically detailing the clinical, regulatory, and drug… Leer más

Descripción

This groundbreaking Theranostic book delivers the definitive roadmap for the next generation of precision oncology by systematically detailing the clinical, regulatory, and drug delivery landscapes of theranostics—the revolutionary integration of therapy and diagnostics—across 20-22 major cancer types. Designed for medical publishers, clinicians, and biotech researchers, this chapter is a structural framework for each malignancy, bridging laboratory breakthroughs in nanotechnology, green nanochemistry, drug delivery, diagnostics, and AI with real-world clinical applications. It serves as an essential commercial and academic asset, offering unprecedented depth on FDA/EMA regulatory hurdles, technology transfer pathways, and actionable data tables that track active clinical trials and global research groups. By addressing key market trends and regulatory challenges, it serves as an essential, multidisciplinary resource for driving personalized oncology and improving patient outcomes

Puntos claves

High-Value Cancer-Specific Market Intel: Analyses the complete theranostic landscape across distinct global cancer markets
End-to-End Translational Roadmap: Connects cutting-edge nanomedicine, green nanotechnology, nanodiamonds, and AI-driven diagnostics directly to practical FDA/EMA regulatory processes and technology transfer workflows
Ready-to-Use Clinical & Research Data: Provides a comprehensive reference suite for tracking ongoing clinical trials, preclinical models, patents, and R&D insights

De interès para

Academics, researchers, clinicians, policymakers, and students in oncology, pharmacy, biomedical sciences, related fields and industry

Índice

1. Introduction

2. Skin Cancer: Theranostic Landscape

3. Lung Cancer: Theranostic Landscape

4. Breast Cancer: Theranostic Landscape

5. Liver and Pancreatic Cancers

6. Kidney and Adrenal Cancers

7. Brain and Central Nervous System Cancers

8. Gastrointestinal Cancers

9. Hematologic Malignancies

10. Market Trends and Emerging Technologies

Detalles del producto

Edición: 1
Última edición
Publicado: 1 de abril de 2027
Idioma: Inglés

Sobre los editores

Ranjita Shegokar

Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)

Afiliaciones y experiencia

Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics, Free University of Berlin, Germany

Yashwant Pathak

Yashwant Pathak is a Professor at Taneja College of Pharmacy at the University of South Florida, FL, United States. His area of research is nanotechnology, drug delivery systems, and nutraceuticals. He is also an Ad junct Professor at the Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia.